CD8-enriched tumor-infiltrating lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD8-enriched tumor-infiltrating lymphocytes, covering 2015-10-26 to 2015-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes [Phase 1, Phase 2]